Page last updated: 2024-08-25

7-hydroxystaurosporine and Acute Promyelocytic Leukemia

7-hydroxystaurosporine has been researched along with Acute Promyelocytic Leukemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cai, X; Ding, M; Liang, C; Sheng, Y; Weng, XQ; Wu, J1

Other Studies

1 other study(ies) available for 7-hydroxystaurosporine and Acute Promyelocytic Leukemia

ArticleYear
The combination of UCN-01 and ATRA triggers differentiation in ATRA resistant acute promyelocytic leukemia cell lines via RAF-1 independent activation of MEK/ERK.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2019, Volume: 126

    Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Neoplasm; Enzyme Activation; Humans; Leukemia, Promyelocytic, Acute; MAP Kinase Kinase 1; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-raf; Staurosporine; Tretinoin

2019